| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |